SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company") today announced the last patient has completed her last visit in AMPREVENCE, the Phase 2b ...
SAN DIEGO, Oct. 20, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced enrollment of the first patient in its pivotal Phase 3 clinical trial evaluating the safety and ...
Chlamydia trachomatis remains the most prevalent bacterial sexually transmitted pathogen globally, with tens of millions of new infections each year. Infection is frequently asymptomatic, particularly ...
It’s almost Valentine’s Day, and nothing says romance like a column about a sexually transmitted infection! The next time you take your adolescent in for a checkup, you may find that your health care ...
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries. New ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The bacteria that causes chlamydia, a common sexually transmitted ...
The first vaccine against chlamydia has passed its first test in humans. About three dozen healthy women were randomly assigned one of two versions of a chlamydia vaccine or a placebo treatment in a ...
Credit: Getty Images. Studies link chlamydia to a high risk of female infertility. How should primary care providers assess for inflammation and tubal patency in affected patients? In 2021, more than ...
Researchers at Umeå University, Sweden, and Michigan State University, USA, have discovered a molecule capable of targeting and killing the Chlamydia trachomatis bacterium, while sparing beneficial ...
It’s caused by a type of bacteria called Chlamydia trachomatis and can affect both men and women. While it’s treatable and curable, chlamydia is often called a “silent infection” because many people ...
In a recent prospective cohort study published in The Lancet Regional Health – Europe, researchers from the Netherlands investigated the risks of reproductive complications after asymptomatic and ...
Pregnant patients tested for STIs in EDs are significantly less likely to receive empiric antibiotics than nonpregnant patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results